Venturi Wealth Management LLC grew its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 1,661.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,213 shares of the company's stock after acquiring an additional 8,690 shares during the period. Venturi Wealth Management LLC's holdings in Bath & Body Works were worth $357,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. FMR LLC boosted its position in Bath & Body Works by 17,496.5% during the third quarter. FMR LLC now owns 2,516,127 shares of the company's stock worth $80,315,000 after acquiring an additional 2,501,828 shares during the last quarter. KBC Group NV lifted its holdings in shares of Bath & Body Works by 9,023.5% in the 3rd quarter. KBC Group NV now owns 1,701,813 shares of the company's stock valued at $54,322,000 after purchasing an additional 1,683,160 shares during the last quarter. Erste Asset Management GmbH purchased a new stake in shares of Bath & Body Works in the 3rd quarter valued at about $50,483,000. Forest Avenue Capital Management LP raised its stake in Bath & Body Works by 19.1% during the 3rd quarter. Forest Avenue Capital Management LP now owns 1,467,763 shares of the company's stock valued at $46,851,000 after acquiring an additional 235,173 shares during the last quarter. Finally, Verition Fund Management LLC increased its position in Bath & Body Works by 111.8% during the 3rd quarter. Verition Fund Management LLC now owns 1,345,777 shares of the company's stock worth $42,957,000 after purchasing an additional 710,333 shares during the period. 95.14% of the stock is currently owned by institutional investors.
Bath & Body Works Stock Performance
Shares of NYSE BBWI traded down $1.84 during mid-day trading on Friday, hitting $38.51. The stock had a trading volume of 5,441,380 shares, compared to its average volume of 3,304,652. The firm has a market cap of $8.34 billion, a P/E ratio of 9.39, a price-to-earnings-growth ratio of 0.95 and a beta of 1.83. The business has a 50 day moving average price of $37.70 and a two-hundred day moving average price of $33.81. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99.
Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same quarter in the prior year, the firm earned $0.48 EPS. The business's revenue for the quarter was up 3.1% compared to the same quarter last year. Equities research analysts predict that Bath & Body Works, Inc. will post 3.26 EPS for the current fiscal year.
Bath & Body Works Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be paid a dividend of $0.20 per share. The ex-dividend date is Friday, February 21st. This represents a $0.80 annualized dividend and a dividend yield of 2.08%. Bath & Body Works's dividend payout ratio is currently 19.51%.
Analyst Ratings Changes
A number of brokerages have commented on BBWI. Deutsche Bank Aktiengesellschaft increased their target price on Bath & Body Works from $51.00 to $52.00 and gave the company a "buy" rating in a report on Tuesday, November 26th. Wells Fargo & Company upgraded Bath & Body Works from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $42.00 to $48.00 in a research note on Friday, January 10th. Piper Sandler raised their target price on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a "neutral" rating in a report on Monday, January 6th. Barclays lifted their price target on Bath & Body Works from $28.00 to $34.00 and gave the company an "underweight" rating in a report on Tuesday, November 26th. Finally, TD Cowen boosted their target price on Bath & Body Works from $42.00 to $48.00 and gave the stock a "buy" rating in a report on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $43.63.
Get Our Latest Stock Analysis on BBWI
Bath & Body Works Company Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Read More
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
